Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Novel 3-methoxybenzyl-benzamide compound for adjusting activity of estrogen-related receptor alpha and medical application thereof

A compound, estrogen technology, used in organic chemistry, amide active ingredients, drug combinations, etc.

Inactive Publication Date: 2017-03-29
QILU UNIV OF TECH
View PDF4 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

These studies suggest that modulators targeting ERRα have the potential to serve as clinically effective antitumor agents

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Novel 3-methoxybenzyl-benzamide compound for adjusting activity of estrogen-related receptor alpha and medical application thereof
  • Novel 3-methoxybenzyl-benzamide compound for adjusting activity of estrogen-related receptor alpha and medical application thereof
  • Novel 3-methoxybenzyl-benzamide compound for adjusting activity of estrogen-related receptor alpha and medical application thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0015] Embodiment 1 uses reporter gene test formula I compound to the transcription regulation activity of ERR-alpha

[0016]

[0017] This example illustrates that the compound of formula I involved in the present invention can effectively inhibit the expression of the reporter gene regulated by ERR-alpha in human embryonic kidney cells HEK-293, indicating that the compound of formula I involved in the present invention can effectively regulate ERR-alpha alpha function. Reporter gene testing techniques are familiar to those skilled in the art.

[0018] We used the GAL4 fusion receptor activation method to test the transcriptional regulation activity of the compound of formula I on ERRs. The GAL4 fusion receptor activation method is based on the one-hybrid principle of mammalian cells, that is, the receptor LBD and the yeast transcription factor DBD are constructed into a fusion protein expression plasmid, and the receptor LBD acts as the activation domain (Activation doma...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a novel 3-methoxybenzyl-benzamide compound, as shown in a formula I which is described in the specification, for adjusting the activity of an estrogen-related receptor alpha and a pharmaceutically salt thereof, and medical application thereof. The compound and the pharmaceutically salt thereof can be used for preparing drugs capable of adjusting the activity of the estrogen-related receptor alpha (ERR-alpha) and preventing and treating malignant tumors like breast cancers, prostatic cancers, stomach cancers, colorectal cancers, ovarian cancer and cervical cancers.

Description

technical field [0001] The present invention relates to a novel 3-methoxybenzyl-benzamide compound and a pharmaceutically acceptable salt thereof as an estrogen-related receptor ERR-alpha (Estrogen-related receptor alpha, ERR-alpha or ERRα) regulator Agents and their drug combinations and their use in the preparation of drugs for the prevention and / or treatment of tumors such as breast cancer, prostate cancer, gastric cancer, colon cancer, ovarian cancer, cervical cancer or endometrial cancer. Background technique [0002] ERRα was cloned and identified by Giguere et al. in 1988. As an orphan nuclear receptor (Orphan nuclear receptor), the endogenous ligand of ERRα has not been discovered. ERRα is widely expressed in the body and can be detected from myocardium, digestive tract, brain, skeletal muscle, brown fat, breast cancer, ovarian cancer and other malignant tumors. ERRα has high homology with estrogen receptor α (ERα): DNA binding domain (DNA binding domain, DBD) amin...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): C07C311/08A61K31/18A61P35/00
CPCA61K31/18C07C311/08
Inventor 杜永丽韩炜炜凌浩李群益
Owner QILU UNIV OF TECH
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com